Erste Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $693K | Hold |
116,850
| – | – | 0.01% | 578 |
|
|
2025
Q1 | $985K | Hold |
116,850
| – | – | 0.01% | 378 |
|
|
2024
Q4 | $1.13M | Hold |
116,850
| – | – | 0.01% | 371 |
|
|
2024
Q3 | $1.25M | Hold |
116,850
| – | – | 0.02% | 367 |
|
|
2024
Q2 | $1.16M | Hold |
116,850
| – | – | 0.02% | 359 |
|
|
2024
Q1 | $1.39M | Hold |
116,850
| – | – | 0.02% | 338 |
|
|
2023
Q4 | $1.7M | Hold |
116,850
| – | – | 0.02% | 309 |
|
|
2023
Q3 | $1.39M | Hold |
116,850
| – | – | 0.02% | 310 |
|
|
2023
Q2 | $1.47M | Hold |
116,850
| – | – | 0.03% | 318 |
|
|
2023
Q1 | $1.27M | Hold |
116,850
| – | – | 0.02% | 324 |
|
|
2022
Q4 | $1.41M | Hold |
116,850
| – | – | 0.03% | 310 |
|
|
2022
Q3 | $1.2M | Hold |
116,850
| – | – | 0.03% | 333 |
|
|
2022
Q2 | $1.26M | Hold |
116,850
| – | – | 0.03% | 327 |
|
|
2022
Q1 | $1.12M | Sell |
116,850
-15,150
| -11% | -$146K | 0.02% | 343 |
|
|
2021
Q4 | $1.58M | Hold |
132,000
| – | – | 0.03% | 319 |
|
|
2021
Q3 | $1.28M | Hold |
132,000
| – | – | 0.03% | 316 |
|
|
2021
Q2 | $1.31M | Hold |
132,000
| – | – | 0.03% | 325 |
|
|
2021
Q1 | $1.24M | Hold |
132,000
| – | – | 0.03% | 322 |
|
|
2020
Q4 | $2.99M | Sell |
132,000
-26,600
| -17% | -$603K | 0.08% | 226 |
|
|
2020
Q3 | $2.23M | Hold |
158,600
| – | – | 0.08% | 232 |
|
|
2020
Q2 | $2.46M | Hold |
158,600
| – | – | 0.1% | 209 |
|
|
2020
Q1 | $1.54M | Hold |
158,600
| – | – | 0.09% | 208 |
|
|
2019
Q4 | $1.54M | Hold |
158,600
| – | – | 0.07% | 235 |
|
|
2019
Q3 | $1.28M | Hold |
158,600
| – | – | 0.07% | 233 |
|
|
2019
Q2 | $1.9M | Hold |
158,600
| – | – | 0.1% | 183 |
|
|
2019
Q1 | $2.13M | Buy |
158,600
+96,000
| +153% | +$1.29M | 0.12% | 165 |
|
|
2018
Q4 | $581K | Buy |
+62,600
| New | +$581K | 0.04% | 290 |
|